✦ LIBER ✦

Stress doses of glucocorticoids in catecholamine dependency: a new therapy for a new syndrome?

✍ Scribed by P. E. Bollaert

Book ID: 105837901
Publisher: Springer
Year: 2000
Tongue: English
Weight: 46 KB
Volume: 26
Category: Article
ISSN: 1432-1238
DOI: 10.1007/s001340050002

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Adaptive doses of irradiation—an approac

Adaptive doses of irradiation—an approach to a new therapy concept for bladder cancer?

✍ Moshe Schaffer; Silke B. Schwarz; Ulrike Kulka; Martin Busch; Eckhart Dühmke 📂 Article 📅 2004 🏛 Springer-Verlag 🌐 English ⚖ 167 KB

Intrafamilial variability in Hurler synd

Intrafamilial variability in Hurler syndrome and Sanfilippo syndrome type A: Implications for evaluation of new therapies

✍ McDowell, Geraldine A. ;Cowan, Tina M. ;Blitzer, Miriam G. ;Greene, Carol L. 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 English ⚖ 416 KB 👁 1 views

Dose-dependent pharmacokinetic study of

Dose-dependent pharmacokinetic study of pefloxacin, a new antibacterial agent, in humans

✍ J. Barre; G. Houin; J. P. Tillement 📂 Article 📅 1984 🏛 John Wiley and Sons 🌐 English ⚖ 334 KB 👁 1 views

A new concept for bisphosphonate therapy

A new concept for bisphosphonate therapy: a rationale for the development of monthly oral dosing of ibandronate

✍ Jean-Yves Reginster; Dieter Felsenberg; Cyrus Cooper; Jacob A. Stakkestad; Paul 📂 Article 📅 2005 🏛 Springer-Verlag 🌐 English ⚖ 241 KB

Oocyte selection: a new model for the ma

Oocyte selection: a new model for the maternal-age dependence of Down syndrome

✍ Chang-Jiang Zheng; Breck Byers 📂 Article 📅 1992 🏛 Springer 🌐 English ⚖ 650 KB

Previously proposed mechanisms for Down syndrome (trisomy 21) have generally invoked a progressive increase in meiotic nondisjunction to explain maternal-age dependence, but models of this sort have failed to predict the observed patterns of marker segregation. Here we propose instead that age-depen

Dose-dependent pharmacokinetics of a new

Dose-dependent pharmacokinetics of a new neuroprotective agent for ischemia-reperfusion damage, KR-31378, in rats

✍ Hee J. Kim; So H. Kim; Sun-O. Kim; Dong-H. Lee; Hong Lim; Sung-E. Yoo; Myung G. 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 108 KB 👁 2 views

## Abstract The dose‐dependent pharmacokinetic parameters of a new neuroprotective agent for ischemia‐reperfusion damage, KR‐31378, were evaluated after intravenous and oral administration, 10, 20, and 50 mg/kg, to rats. After intravenous administration of 50 mg/kg, the dose‐normalized (10 mg/kg) A